Decoding the influence of central LEAP2 on food intake and its effect on accumbal dopamine release.

Maximilian Tufvesson-Alm, Qian Zhang, Cajsa Aranäs, Sebastian Blid Sköldheden, Christian E Edvardsson, Elisabet Jerlhag

Progress in neurobiology 2024 May

filter terms:

The gut-brain peptide ghrelin and its receptor are established as a regulator of hunger and reward-processing. However, the recently recognized ghrelin receptor inverse agonist, liver-expressed antimicrobial peptide 2 (LEAP2), is less characterized. The present study aimed to elucidate LEAP2s central effect on reward-related behaviors through feeding and its mechanism. LEAP2 was administrated centrally in mice and effectively reduced feeding and intake of palatable foods. Strikingly, LEAP2s effect on feeding was correlated to the preference of the palatable food. Further, LEAP2 reduced the rewarding memory of high preference foods, and attenuated the accumbal dopamine release associated with palatable food exposure and eating. Interestingly, LEAP2 was widely expressed in the brain, and particularly in reward-related brain areas such as the laterodorsal tegmental area (LDTg). This expression was markedly altered when allowed free access to palatable foods. Accordingly, infusion of LEAP2 into LDTg was sufficient to transiently reduce acute palatable food intake. Taken together, the present results show that central LEAP2 has a profound effect on dopaminergic reward signaling associated with food and affects several aspects of feeding. The present study highlights LEAP2s effect on reward, which may have applications for obesity and other reward-related psychiatric and neurological disorders. Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Citation

Maximilian Tufvesson-Alm, Qian Zhang, Cajsa Aranäs, Sebastian Blid Sköldheden, Christian E Edvardsson, Elisabet Jerlhag. Decoding the influence of central LEAP2 on food intake and its effect on accumbal dopamine release. Progress in neurobiology. 2024 May;236:102615